Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 506021 - 506040 out of 558245 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Sweden | (L01EA01) imatinib (adm: O) | Imatinib Accord | 30, 400 mg , Blister, 30 tabletter (plast/Al) (PD: Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | AbacusMedicineA/S |
| Sweden | (L01EA01) imatinib (adm: O) | Imatinib Accord | 30, 400 mg , Blister, 30 tabletter (plast/Al) (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Dermatofibrosarcoma;Myelodysplastic-Myeloproliferative Diseases;Leukemia, Myelogenous, Chronic, BCR-ABL Positive;Hypereosinophilic Syndrome | MedartuumAB |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 30, 100 mg , Burk, 30 tabletter (PD: Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | OrifarmAB |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 30, 100 mg , Burk, 30 tabletter (PD: Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | AbacusMedicineA/S |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 30, 100 mg , Blister, 30 x 1 tabletter (endos) (PD: Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | AbacusMedicineA/S |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 30, 100 mg , Burk, 30 tabletter (PD: 2care4 ApS) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2care4ApS |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 30, 100 mg , Burk, 30 tabletter (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | MedartuumAB |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 30, 100 mg , Blister, 30 x 1 tabletter (endos) (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | MedartuumAB |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 30, 140 mg , Burk, 30 tabletter (PD: Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | OrifarmAB |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 30, 140 mg , Blister, 30 x 1 tabletter (endos) (PD: Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | OrifarmAB |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 60, 20 mg , Burk, 60 tabletter (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | MedartuumAB |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 60, 20 mg , Burk, 60 tabletter (PD: Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | AbacusMedicineA/S |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 60, 20 mg , Burk, 60 tabletter (PD: Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | OrifarmAB |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 60, 50 mg , Burk, 60 tabletter (PD: Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | AbacusMedicineA/S |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 60, 50 mg , Blister, 60 x 1 tabletter (endos) (PD: Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | AbacusMedicineA/S |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 60, 50 mg , Burk, 60 tabletter (PD: Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | OrifarmAB |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 60, 50 mg , Burk, 60 tabletter (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | MedartuumAB |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 60, 70 mg , Burk, 60 tabletter (PD: Orifarm AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | OrifarmAB |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 60, 70 mg , Burk, 60 tabletter (PD: Abacus Medicine A/S) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | AbacusMedicineA/S |
| Sweden | (L01EA02) dasatinib (adm: O) | Sprycel | 60, 70 mg , Burk, 60 tabletter (PD: Medartuum AB) | Retail price without vat |
$0-0 |
$0-0 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive | MedartuumAB |
Pages
